|
Presentations in this session:
13:00 WEPDB101 Abstract | High rates of vitamin D deficiency among HIV-infected and at-risk women in the United States Presented by Oluwatoyin M Adeyemi, United States O.M. Adeyemi1, D. Agniel1, A. French1, K. Weber1, P.C. Tien2, M. Glesby3, E. Golub4, D. Merenstein5, A. Sharma6, M.C. Villacres7, M. Cohen1, WIHS study group 1CORE Center, Cook County Hospital, Chicago, United States, 2University of California San Francisco (UCSF), San Francisco, United States, 3Cornell Weil Medical College, New York, United States, 4John Hopkins School of Public Health, Baltimore, United States, 5Georgetown University, Washington, United States, 6New York University School of Medicine, New York, United States, 7University of Southern California, Los Angeles, United States
| 13:05 WEPDB102 Abstract | High prevalence of vitamin D deficiency among HIV-infected patients Presented by Catherine Chien, United States C. Chien, C. Carlotti, L. Bhatti, P. Jongthavorn, P. Denouden, M. Valdes-Suerias, S. Sayana, H. Khanlou AIDS Healthcare Foundation, Department of Medicine, Los Angeles, United States
| 13:10 WEPDB103 Abstract | Risk factors for vitamin D deficiency in HIV-1 infected adults in the South-Central United States Presented by Rustin Crutchley, United States R. Crutchley1,2, J. Gathe Jr.2 1University of Houston, Houston, United States, 2Therapeutic Concepts, Inc., Houston, United States
| 13:15 WEPDB104 Abstract | Evaluation of vitamin D levels in HIV-infected patients at the Center of Comprehensive Care, St Luke´s Roosevelt Hospital Center, New York, USA Presented by Vani Gandhi, United States V. Gandhi1, J.H. Kim2, G. Psevdos Jr.1, F. Espinoza3, J. Park4, V. Sharp4 1Center for Comprehensive Care, St Luke's Roosevelt Hospital, Infectious Diseases, New York, United States, 2University of Pittsburgh Medical Center, Infectious Diseases, Pittsburgh, United States, 3St Luke's Roosevelt Hospital, Medicine, New York, United States, 4Center for Comprehensive Care, St Luke's Roosevelt Hospital, New York, United States
| 13:20 WEPDB105 Abstract | No
association of vitamin D levels with individual antiretroviral agents, duration
of HIV-infection, alkaline phosphatase levels nor bone mineral density findings Presented by Emma Devitt, United Kingdom T. Rachid, E. Devitt, I. Meyron, S. Mandalia, L. Waters, M. Bower, R. Jones, M. Nelson Chelsea and Westminster Hospital, HIV Medicine, London, United Kingdom
| 13:25 WEPDB106 Abstract | Prevalence of hypovitaminosis D and factors associated in a sample of HIV patients Presented by Daria Pocaterra, Italy D. Pocaterra1, E. Ricci1, L. Carenzi1, M. Schiavini1, P. Meraviglia1, D. Minisci1, M. Campaniello1, C. Gervasoni1, M. Bevilacqua2, G. Rizzardini1, P. Bonfanti1 1L.Sacco Hospital, Infectious Diseases, Milan, Italy, 2L.Sacco Hospital, Endocrinologic Unit, Milan, Italy
|
|